Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.

Asano, Daigo et al.·Pharmaceutics·2023·
RPEP-066992023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Oral bioavailability of peptides in Rybelsus and Mycapssa is around 1%.

Key Numbers

How They Did This

The article reviews recent advancements and technologies aimed at enhancing the oral absorption of middle-to-large molecules.

Why This Research Matters

Improving the oral absorption of larger molecules could lead to more effective and convenient treatments for various conditions. This is particularly important for patients who prefer oral medications over injections.

What This Study Doesn't Tell Us

The review primarily focuses on existing drugs and does not present new experimental data or clinical trials.

Trust & Context

Original Title:
Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.
Published In:
Pharmaceutics, 16(1) (2023)
Database ID:
RPEP-06699

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06699·https://rethinkpeptides.com/research/RPEP-06699

APA

Asano, Daigo; Takakusa, Hideo; Nakai, Daisuke. (2023). Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.. Pharmaceutics, 16(1). https://doi.org/10.3390/pharmaceutics16010047

MLA

Asano, Daigo, et al. "Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.." Pharmaceutics, 2023. https://doi.org/10.3390/pharmaceutics16010047

RethinkPeptides

RethinkPeptides Research Database. "Oral Absorption of Middle-to-Large Molecules and Its Improve..." RPEP-06699. Retrieved from https://rethinkpeptides.com/research/asano-2023-oral-absorption-of-middletolarge

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.